{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:54:35Z","timestamp":1793717675997,"version":"4.6.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41440-024-01984-1","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:42:16Z","timestamp":1731588136000},"page":"414-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beyond pharmacotherapy: bilateral adrenal artery embolization as a potential game-changer for idiopathic hyperaldosteronism patients"],"prefix":"10.1038","volume":"48","author":[{"given":"Hironobu","family":"Umakoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"1984_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"1984_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:41\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1210\/jc.2017-01774","volume":"103","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, et al. Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2018;103:900\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1984_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41581-023-00753-6","volume":"19","author":"EAB Azizan","year":"2023","unstructured":"Azizan EAB, Drake WM, Brown MJ. Primary aldosteronism: molecular medicine meets public health. Nat Rev Nephrol. 2023;19:788\u2013806.","journal-title":"Nat Rev Nephrol"},{"key":"1984_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","volume":"144","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-Based Adrenal Ablation Remits Primary Aldosteronism: A Randomized Medication-Controlled Trial. Circulation. 2021;144:580\u20132.","journal-title":"Circulation"},{"key":"1984_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41440-023-01420-w","volume":"47","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Wang X, Hou J, Wan J, Yang Y, Liu S, et al. A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism. Hypertens Res. 2024;47:311\u201321.","journal-title":"Hypertens Res"},{"key":"1984_CR7","doi-asserted-by":"publisher","unstructured":"Ji G, Yang C, Hou J, Zhou Y, Luo T, Yang Y, et al. Bilateral adrenal artery embolization for the treatment of idiopathic hyperaldosteronism: A proof-of-principle single center study. Hypertens Res. 2024. https:\/\/doi.org\/10.1038\/s41440-024-01897-z.","DOI":"10.1038\/s41440-024-01897-z"},{"key":"1984_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41440-020-00579-w","volume":"44","author":"K Nishimoto","year":"2021","unstructured":"Nishimoto K, Umakoshi H, Seki T, Yasuda M, Araki R, Otsuki M, et al. Diverse pathological lesions of primary aldosteronism and their clinical significance. Hypertens Res 2021;44:498\u2013507.","journal-title":"Hypertens Res"},{"key":"1984_CR9","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto K, Tomlins SA, Kuick R, Cani AK, Giordano TJ, Hovelson DH, et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci USA. 2015;112:E4591\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1984_CR10","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1210\/clinem\/dgac394","volume":"107","author":"N Iwahashi","year":"2022","unstructured":"Iwahashi N, Umakoshi H, Seki T, Gomez-Sanchez CE, Mukai K, Suematsu M, et al. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution. J Clin Endocrinol Metab. 2022;107:2439\u201348.","journal-title":"J Clin Endocrinol Metab"},{"key":"1984_CR11","doi-asserted-by":"publisher","first-page":"e4580","DOI":"10.1210\/clinem\/dgab459","volume":"106","author":"M Yokomoto-Umakoshi","year":"2021","unstructured":"Yokomoto-Umakoshi M, Umakoshi H, Iwahashi N, Matsuda Y, Kaneko H, Ogata M, et al. Protective role of DHEAS in age-related changes in bone mass and fracture risk. J Clin Endocrinol Metab. 2021;106:e4580\u2013e4592.","journal-title":"J Clin Endocrinol Metab"},{"key":"1984_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa2213169","volume":"388","author":"MW Freeman","year":"2023","unstructured":"Freeman MW, Halvorsen YD, Marshall W, Pater M, Isaacsohn J, Pearce C, et al. Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. N. Engl J Med. 2023;388:395\u2013405.","journal-title":"N. Engl J Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01984-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01984-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01984-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:41:24Z","timestamp":1736138484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01984-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01984-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}